WO2008015703A3 - Procédé pour la préparation de montelukast et de ses sels - Google Patents

Procédé pour la préparation de montelukast et de ses sels Download PDF

Info

Publication number
WO2008015703A3
WO2008015703A3 PCT/IN2007/000314 IN2007000314W WO2008015703A3 WO 2008015703 A3 WO2008015703 A3 WO 2008015703A3 IN 2007000314 W IN2007000314 W IN 2007000314W WO 2008015703 A3 WO2008015703 A3 WO 2008015703A3
Authority
WO
WIPO (PCT)
Prior art keywords
montelukast
preparation
salts
amine salts
conversion
Prior art date
Application number
PCT/IN2007/000314
Other languages
English (en)
Other versions
WO2008015703A2 (fr
Inventor
Seeta Ramanjaneyulu Gorantla
Mohan Bandari
Venkata Sunil Kumar Indukuri
Srinivas Simhadri
Narsimha Rao Ketavarapu
Venkata Krishna Kishore Jammulaveera
Yaseen Mohammed
Original Assignee
Matrix Lab Ltd
Seeta Ramanjaneyulu Gorantla
Mohan Bandari
Venkata Sunil Kumar Indukuri
Srinivas Simhadri
Narsimha Rao Ketavarapu
Venkata Krishna Kishore Jammulaveera
Yaseen Mohammed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matrix Lab Ltd, Seeta Ramanjaneyulu Gorantla, Mohan Bandari, Venkata Sunil Kumar Indukuri, Srinivas Simhadri, Narsimha Rao Ketavarapu, Venkata Krishna Kishore Jammulaveera, Yaseen Mohammed filed Critical Matrix Lab Ltd
Priority to EP07827527A priority Critical patent/EP2069307A4/fr
Priority to US12/376,354 priority patent/US20110092708A1/en
Publication of WO2008015703A2 publication Critical patent/WO2008015703A2/fr
Publication of WO2008015703A3 publication Critical patent/WO2008015703A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Quinoline Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne les sels d'alkyl amine de Montelukast et des procédés pour leur préparation et la conversion de sels d'amine de Montelukast en un sel de Montelukast ou un sel d'alcali / alcalin de Montelukast.
PCT/IN2007/000314 2006-08-04 2007-07-31 Procédé pour la préparation de montelukast et de ses sels WO2008015703A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP07827527A EP2069307A4 (fr) 2006-08-04 2007-07-31 Procédé pour la préparation de montelukast et de ses sels
US12/376,354 US20110092708A1 (en) 2006-08-04 2007-07-31 Process for the preparation of montelukast and its salts thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1400CH2006 2006-08-04
IN1400/CHE/2006 2006-08-04

Publications (2)

Publication Number Publication Date
WO2008015703A2 WO2008015703A2 (fr) 2008-02-07
WO2008015703A3 true WO2008015703A3 (fr) 2009-04-09

Family

ID=38997582

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2007/000314 WO2008015703A2 (fr) 2006-08-04 2007-07-31 Procédé pour la préparation de montelukast et de ses sels

Country Status (3)

Country Link
US (1) US20110092708A1 (fr)
EP (1) EP2069307A4 (fr)
WO (1) WO2008015703A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2358923T3 (es) 2005-07-05 2011-05-16 Teva Pharmaceutical Industries, Ltd. Purificación de montelukast.
EP1886998A1 (fr) 2006-08-09 2008-02-13 Esteve Quimica, S.A. Procédés de purification du montelukast et ses sels d'amine
CZ302518B6 (cs) * 2007-07-09 2011-06-29 Zentiva, A. S. Zpusob izolace a cištení montelukastu
DE102007061630B4 (de) * 2007-12-20 2013-07-04 Formosa Laboratories, Inc. Neue Verbindungen und Herstellung von Montelukast-Natrium
EP2552892A1 (fr) 2010-03-31 2013-02-06 KRKA, D.D., Novo Mesto Synthèse efficace pour la préparation de montélukast et nouvelle forme cristalline d'intermédiaires dans celle-ci
US9102665B2 (en) * 2011-07-26 2015-08-11 Sun Pharma Advanced Research Company Ltd. Cysteinyl leukotriene antagonists
US9487487B2 (en) * 2012-05-18 2016-11-08 Laurus Labs Private Limited Process for preparation of montelukast sodium

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006058545A1 (fr) * 2004-11-30 2006-06-08 Medichem, S.A. Nouveau procede de preparation d'un antagoniste de leucotriene
US20060194839A1 (en) * 2005-02-18 2006-08-31 Chemi Spa Process for the preparation of Montelukast
WO2007004237A2 (fr) * 2005-07-05 2007-01-11 Matrix Laboratories Ltd Procede de preparation de montelukast
WO2007069261A1 (fr) * 2005-12-13 2007-06-21 Msn Laboratories Limited Procede ameliore de preparation de montelukast et de ses sels pharmaceutiquement acceptables

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565473A (en) * 1990-10-12 1996-10-15 Merck Frosst Canada, Inc. Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
TW448160B (en) * 1993-12-28 2001-08-01 Merck & Co Inc Novel dicyclohexylamine salt and process for the preparation of leukotriene antagonists
US20050107612A1 (en) * 2002-12-30 2005-05-19 Dr. Reddy's Laboratories Limited Process for preparation of montelukast and its salts
WO2006008750A2 (fr) * 2004-07-19 2006-01-26 Matrix Laboratories Ltd Methyl 2-[(3s)-[3-[(2e)-(7-chloro quinolin-2-yl) ethenyl] phenyl]-3-halopropyl] benzoates
EP1812394B1 (fr) * 2004-07-19 2011-03-02 Matrix Laboratories Ltd Procede de preparation de montelukast et de ses sels
PL205637B1 (pl) * 2004-10-22 2010-05-31 Inst Farmaceutyczny Sposób wytwarzania kwasu (R,E)-(1-{1-{3-[2-(7-chlorochinolin-2-ylo)etenylo]fenylo}-3-[2-(1-hydroksy-1-metyloetylo)fenylo] propylosulfanylometylo}cyklopropylo)octowego i/lub jego farmaceutycznie dopuszczalnych soli

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006058545A1 (fr) * 2004-11-30 2006-06-08 Medichem, S.A. Nouveau procede de preparation d'un antagoniste de leucotriene
US20060194839A1 (en) * 2005-02-18 2006-08-31 Chemi Spa Process for the preparation of Montelukast
WO2007004237A2 (fr) * 2005-07-05 2007-01-11 Matrix Laboratories Ltd Procede de preparation de montelukast
WO2007069261A1 (fr) * 2005-12-13 2007-06-21 Msn Laboratories Limited Procede ameliore de preparation de montelukast et de ses sels pharmaceutiquement acceptables

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2069307A4 *

Also Published As

Publication number Publication date
US20110092708A1 (en) 2011-04-21
EP2069307A2 (fr) 2009-06-17
EP2069307A4 (fr) 2010-03-03
WO2008015703A2 (fr) 2008-02-07

Similar Documents

Publication Publication Date Title
WO2009114181A3 (fr) Solide de gamma-carbolines fusionnées à hétérocycles substitués
WO2008015703A3 (fr) Procédé pour la préparation de montelukast et de ses sels
HRP20130456T1 (en) Novel process for the preparation of amino acid derivatives
WO2008155615A3 (fr) Procédé perfectionné pour la préparation d'un antibiotique de la famille des céphalosporines
WO2010001257A3 (fr) Nouvelles formes à l’état solide de laquinimod et son sel de sodium
WO2008053334A3 (fr) Procédé amélioré de préparation de rosuvastatine calcique
WO2008058118A3 (fr) Préparation de montélukast et de ses sels
WO2011024192A3 (fr) Nouveaux polymorphes du raltegravir
WO2008111096A3 (fr) Nouveaux promédicaments
MX2011009898A (es) Proceso para la obtencion de derivados de acido propionico.
WO2012038979A3 (fr) Procédé de préparation d'ertapénem
WO2010035284A3 (fr) Procédé amélioré de préparation de calcium de rosuvastatine
WO2008075205A3 (fr) Procédé amélioré de préparation de la voriconazole
WO2010006904A3 (fr) Nouvelles formes cristallines du rabéprazole sodique
WO2010015656A3 (fr) Nouveaux alcoxypyrazoles
WO2007137098A3 (fr) Composés bicycliques sulfonyl-substitués en tant que modulateurs de ppar
IL207431A0 (en) New process for the preparation of cyclohexanecarboxylic acid derivatives
WO2011058524A3 (fr) Formes cristallines du sel de bosentan et leurs procédés de préparation
WO2012063115A3 (fr) Procédé de préparation de rosuvastatine calcique via un nouvel intermédiaire amine
WO2010027848A3 (fr) Formes de composés de lapatinib et procédés pour leur préparation
WO2009062659A3 (fr) Polymorphes d'erdostéine énantiopure
WO2008059519A3 (fr) Procédé pour la préparation d'intermédiaires de rosuvastatine
WO2007013043A3 (fr) Procedes d'elaboration d'acide 7-amino-3-vinyl cephalosporanique
WO2009060297A3 (fr) Procédé perfectionné pour la préparation de la palipéridone et de ses intermédiaires
WO2011004282A3 (fr) Nouvelle forme polymorphe de sels de teriflunomide

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07827527

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 12376354

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007827527

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: RU